Expression of SLP-2 Was Associated with Invasion of Esophageal Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Cao, Wenfeng ^a,b   Zhang, Bin ^a   Ding, Fang ^b   Zhang, Weiran ^a   Sun, Baocun ^a   Liu, Zhihua ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MK-2206; RNA; SMALL INTERFERING RNA; STOMATIN; STOMATIN LIKE PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING;

BLOOD PROTEINS; BLOTTING, WESTERN; BUTADIENES; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NITRILES; RNA INTERFERENCE;

EID: 84877267181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063890     Document Type: Article

References (25)

1. Segal E, Friedman N, Kaminski N, Regev A, Koller D, (2005) From signatures to models: understanding cancer using microarrays. Nat Genet 37: S38-45.
2. Luo A, Kong J, Hu G, Liew CC, Xiong M, et al. (2004) Discovery of Ca2+-relevant and differentiation- associated genes down-regulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299.
3. Lu J, Liu Z, Xiong M, Wang Q, Wang X, et al. (2001) Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 91: 288-294.
4. Zhi H, Zhang J, Hu G, Lu J, Wang X, et al. (2003) The deregulation of arachidonic acid metabolism- related genes in human squamous cell carcinoma. Int J Cancer 106: 327-333.
5. Wang Y, Morrow JS, (2000) Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem 275: 8062-8071.
6. Owczarek CM, Treutlein HR, Portbury KJ, Gulluyan LM, Kola I, et al. (2001) A novel member of the STOMATIN/EPB72/mec-2 family, stomatin-like 2 (STOML2), is ubiquitously expressed and localizes to HSA chromosome 9p13.1. Cytogenet Cell Genet 92: 196-203.
7. Zhang LY, Wang T, Ding F, Liu ZM, Liu ZH, et al. (2004) Differential expression and bioinformatics analysis of SLP-2 gene in esophageal squamous cell carcinoma. World Chin J Digestol 12: 1517-1521.
8. Zhang LY, Ding F, Liu ZM, Li WD, Liu ZH, et al. (2005) Effect of stomatin-like protein 2 (SLP-2) gene on growth and proliferation esophageal squamous cell carcinoma cell line TE12. Ai Zheng 24: 155-159.
9. Zhang L, Ding F, Cao W, Liu Z, Liu W, et al. (2006) Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res 12: 1639-1646.
10. Cao WF, Zhang LY, Liu MB, Tang PZ, Liu ZH, et al. (2007) Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histological and immunohistochemistry analysis with tissue microarray. Hum Pathol 38: 747-752.
11. Cao W, Zhang B, Liu Y, Li H, Zhang S, et al. (2007) High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol 128: 430-436.
12. Wang Y, Cao W, Yu Z, Liu Z, (2009) Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagents. Cancer Biol Ther 8: 1651-1658.
13. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T, (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284.
14. Cao W, Zhang B, Li J, Liu Y, Liu Z, et al. (2011) SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer. Pathology 43: 713-718.
15. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
16. Ohike N, Coban I, Kim GE, Basturk O, Tajiri T, et al. (2010) Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. Am J Surg Pathol 34: 1417-1424.
17. Ljuslinder I, Melin B, Henriksson ML, Oberg A, Palmqvist R, (2011) Increased EGFR expression at the invasive margin is a negative prognostic factor in colorectal cancer. Int J Cancer 128: 2031-2037.
18. Brown M, Sillah K, Griffiths EA, Swindell R, West CM, et al. (2010) Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology 56: 893-899.
19. Groblewska M, Siewko M, Mroczko B, Szmitkowski M, (2012) The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. Folia Histochem Cytobiol 50: 12-19.
20. Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y, et al. (2008) TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. BMC Cancer 8: 189-204.
21. Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR, (1998) In situ visualization of intratumour growth factor signaling: immunohistochemical localization of activated Erk/MAP kinase in glial neoplasms. Am J Pathol 153: 1411-1423.
22. Adeyinka A, Nui Y, Cherlet T, Snell L, Watson PH, et al. (2002) Activated mitogen-activated protein kinase expression during human breast tumourigenesis and breast cancer progression. Clin Cancer Res 8: 1747-1753.
23. Albanell J, Codony-Servat J, Rojo F, Del Campo JM, Sauleda S, et al. (2001) Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 61: 6500-6510.
24. Tasioudi KE, Saetta AA, Sakellariou S, Levidou G, Michalopoulos NV, et al. (2012) pERK activation in esophageal carcinomas: clinicopathological associations. Pathol Res Pract 208: 398-404.
25. Zhang J, Zhi H, Zhou C, Ding F, Luo A, et al. (2005) Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway. J Pathol 207: 402-409.